Cited by 226Bariatric Surgery and OutcomesLiver Disease Diagnosis and TreatmentMinimally Invasive Surgical Techniques

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Roux-en-Y Gastric Bypass Versus Adjustable Gastric Banding to Reduce Nonalcoholic Fatty Liver Disease: A 5-Year Controlled Longitudinal Study

Caiazzo, Robert, Lassailly, Guillaume, Leteurtre, Emmanuelle, Baud, Gregory, Verkindt, Hélène, Raverdy, Violeta, Buob, David, Pigeyre, Marie, Mathurin, Philippe, Pattou, François·2014·Annals of Surgery

DOI 10.1097/sla.0000000000000945

Open this paper in CoChat — free account

Abstract

In Brief Objectives: To compare the long-term benefit of gastric bypass [Roux-en-Y gastric bypass (RYGB)] versus adjustable gastric banding (AGB) on nonalcoholic fatty liver disease (NAFLD) in severely obese patients. Background: NAFLD improves after weight loss surgery, but no histological study has compared the effects of the various bariatric interventions. Methods: Participants consisted of 1236 obese patients (body mass index = 48.4 ± 7.6 kg/m2), enrolled in a prospective longitudinal study for up to 5 years after RYGB (n = 681) or AGB (n = 555). Liver biopsy samples were available for 1201 patients (97.2% of those at risk) at baseline, 578 patients (47.2%) at 1 year, and 413 patients (68.9%) at 5 years. Results: At baseline, NAFLD was present in 86% patients and categorized as severe [NAFLD activity score (NAS) ≥3] in 22% patients. RYGB patients had a higher body mass index (49.8 ± 8.2 vs 46.8 ± 6.5 kg/m2, P < 0.001) and more severe NAFLD (NAS: 2.0 ± 1.5 vs 1.7 ± 1.4, P = 0.004) than AGB patients. Weight loss at 5 years was 25.5% ± 11.8% after RYGB versus 21.4% ± 12.7% after AGB (P < 0.001). When analyzed with a mixed model, all NAFLD parameters improved after surgery (P < 0.001) and improved significantly more after RYGB than after AGB [steatosis (%): 1 year, 7.9 ± 13.7 vs 17.9 ± 21.5, P < 0.001/5 years, 8.7 ± 7.1 vs 14.5 ± 20.8, P < 0.05; NAS: 1 year, 0.7 ± 1.0 vs 1.1 ± 1.2, P < 0.001/5 years, 0.7 ± 1.2 vs 1.0 ± 1.3, P < 0.05]. In multivariate analysis, the superiority of RYGB was primarily but not entirely explained by weight loss. Conclusions: The improvement of NAFLD was superior after RYGB than after AGB. We enrolled 1236 obese patients in a longitudinal study with sequential liver biopsies before and after gastric bypass [Roux-en-Y gastric bypass (RYGB)] or gastric banding [adjustable gastric banding (AGB)]. Nonalcoholic fatty liver disease improved from baseline to 5 years after both interventions but more significantly after RYGB than after AGB. In multivariate analysis, the superiority of RYGB was primarily but not entirely explained by weight loss.

Integrity signals

Registry

Crossref · 10.1097/sla.0000000000000945

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
De Vadder, F., Kovatcheva-Datchary, P., Goncalves, D., Vinera, J., Zitoun, C., Duchampt, A., Bäckhed, F., & Mithieux, G. (2014) · Cell · doi:10.1016/j.cell.2013.12.016 · Cited by 2,200
Review of the key results from the Swedish Obese Subjects ( SOS ) trial – a prospective controlled intervention study of bariatric surgery
Sjöström, L. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12012 · Cited by 1,835
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,805
Statistics notes: Calculating correlation coefficients with repeated observations: Part 1—correlation within subjects
Bland, J. M., & Altman, D. G. (1995) · BMJ · doi:10.1136/bmj.310.6977.446 · Cited by 1,036
Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference statement.
(1992) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.2.615s · Cited by 748
Bile acid receptors as targets for drug development
Schaap, F. G., Trauner, M., & Jansen, P. L. M. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.151 · Cited by 696
Long-Term Outcomes After Bariatric Surgery
O’Brien, P. E., MacDonald, L., Anderson, M. L., Brennan, L., & Brown, W. A. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e31827b6c02 · Cited by 545
The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver diseasePowell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years [Hepatology 1990; 11:74–80]
Caldwell, S. H., & Crespo, D. M. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.02.013 · Cited by 499

Show all 21 references

Sorted by citations

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Pοlyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2018) · Metabolism · doi:10.1016/j.metabol.2018.11.014 · Cited by 1,264
NAFLD and diabetes mellitus
Tilg, H., Moschen, A. R., & Roden, M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.147 · Cited by 1,002
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
Lassailly, G., Caiazzo, R., Buob, D., Pigeyre, M., Verkindt, H., Labreuche, J., Raverdy, V., Leteurtre, E., Dharancy, S., Louvet, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.014 · Cited by 762
Self-citation
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), & European Association for the Study of Obesity (EASO) (2016) · Diabetologia · doi:10.1007/s00125-016-3902-y · Cited by 695
ESPEN guideline on clinical nutrition in liver disease
Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schütz, T., & Bischoff, S. C. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.12.022 · Cited by 674
Treatment of Obesity
Wolfe, B. M., Kvach, E., & Eckel, R. H. (2016) · Circulation Research · doi:10.1161/circresaha.116.307591 · Cited by 695
NAFLD as a Continuum: From Obesity to Metabolic Syndrome and Diabetes
Godoy-Matos, A. F., Silva Júnior, W. S., & Valerio, C. M. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00570-y · Cited by 643
Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures – 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.10.025 · Cited by 608
Dysregulated lipid metabolism links NAFLD to cardiovascular disease
Deprince, A., Haas, J. T., & Staels, B. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101092 · Cited by 576
EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
European Association for the Study of the Liver (EASL), E. A. F. T. S. O. D. (. (2016) · Obesity Facts · doi:10.1159/000443344 · Cited by 531
Clinical Practice Guidelines For The Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures – 2019 Update: Cosponsored By American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society For Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0406 · Cited by 510
Bariatric surgery and long-term nutritional issues
Lupoli, R., Lembo, E., Saldalamacchia, G., Avola, C. K., Angrisani, L., & Capaldo, B. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i11.464 · Cited by 454
Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
Haas, J. T., Francque, S., & Staels, B. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105331 · Cited by 411
Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures – 2019 Update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists
Mechanick, J. I., Apovian, C. M., Brethauer, S. A., Garvey, W. T., Joffe, A. M., Kim, J. J., Kushner, R. F., Lindquist, R., Pessah‐Pollack, R., Seger, J., et al. (2020) · Obesity · doi:10.1002/oby.22719 · Cited by 425
ESPEN practical guideline: clinical nutrition in liver disease
Bischoff, S. C., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schütz, T., & Plauth, M. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.09.001 · Cited by 383
Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis
Lee, Y., Doumouras, A. G., Yu, J., Brar, K., Banfield, L., Gmora, S., Anvari, M., & Hong, D. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.10.017 · Cited by 371
Therapeutic pipeline in nonalcoholic steatohepatitis
Vuppalanchi, R., Noureddin, M., Alkhouri, N., & Sanyal, A. J. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00408-y · Cited by 278
Non-alcoholic fatty liver disease: A patient guideline
Francque, S. M., Marchesini, G., Kautz, A., Walmsley, M., Dorner, R., Lazarus, J. V., Zelber-Sagi, S., Hallsworth, K., Busetto, L., Frühbeck, G., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100322 · Cited by 264
Bariatric surgery improves nonalcoholic fatty liver disease: A contemporary systematic review and meta-analysis
Fakhry, T. K., Mhaskar, R., Schwitalla, T., Muradova, E., Gonzalvo, J. P., & Murr, M. M. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.12.002 · Cited by 259
Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology
Bower, G., Toma, T., Harling, L., Jiao, L. R., Efthimiou, E., Darzi, A. W., Athanasiou, T., & Ashrafian, H. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1691-x · Cited by 261
The bariatric surgery and weight losing: a meta-analysis in the long- and very long-term effects of laparoscopic adjustable gastric banding, laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy on weight loss in adults
Golzarand, M., Toolabi, K., & Farid, R. (2017) · Surgical Endoscopy · doi:10.1007/s00464-017-5505-1 · Cited by 200
Management of non-alcoholic fatty liver disease
Petroni, M. L., Brodosi, L., Bugianesi, E., & Marchesini, G. (2021) · BMJ · doi:10.1136/bmj.m4747 · Cited by 193
Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects
Laursen, T. L., Hagemann, C. A., Wei, C., Kazankov, K., Thomsen, K. L., Knop, F. K., & Grønbæk, H. (2019) · World Journal of Hepatology · doi:10.4254/wjh.v11.i2.138 · Cited by 176
Nonalcoholic Fatty Liver Disease and Obesity Treatment
Brunner, K. T., Henneberg, C. J., Wilechansky, R. M., & Long, M. T. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00345-1 · Cited by 172
Bile Diversion in Roux-en-Y Gastric Bypass Modulates Sodium-Dependent Glucose Intestinal Uptake
Baud, G., Daoudi, M., Hübert, T., Raverdy, V., Pigeyre, M., Hervieux, E., Devienne, M., Ghunaim, M., Bonner, C., Quenon, A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.01.018 · Cited by 129
Self-citation
Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota
Doulberis, M., Kotronis, G., Gialamprinou, D., Kountouras, J., & Katsinelos, P. (2017) · Metabolism · doi:10.1016/j.metabol.2017.03.013 · Cited by 117
Prevention and treatment of nutritional complications after bariatric surgery
Nuzzo, A., Czernichow, S., Hertig, A., Ledoux, S., Poghosyan, T., Quilliot, D., Gall, M. L., Bado, A., & Joly, F. (2021) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(20)30331-9 · Cited by 115
The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome
Aguilar-Olivos, N. E., Almeda-Valdes, P., Aguilar-Salinas, C. A., Uribe, M., & Méndez-Sánchez, N. (2016) · Metabolism · doi:10.1016/j.metabol.2015.09.004 · Cited by 100
Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025
Roeb, E., Canbay, A. E., Tacke, F., Bantel, H., Bojunga, J., de Laffolie, J., Demir, M., Denzer, U. W., Geier, A., Hofmann, W. P., et al. (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1880-2283 · Cited by 108
Increased Hepatic PDGF-AA Signaling Mediates Liver Insulin Resistance in Obesity-Associated Type 2 Diabetes
Abderrahmani, A., Yengo, L., Caiazzo, R. J., Canouil, M., Cauchi, S., Raverdy, V., Plaisance, V., Pawlowski, V., Lobbens, S., Maillet, J., et al. (2018) · Diabetes · doi:10.2337/db17-1539 · Cited by 105
Self-citation
Practice patterns in NAFLD and NASH: real life differs from published guidelines
Rinella, M. E., Lominadze, Z., Loomba, R. S., Charlton, M., Neuschwander‐Tetri, B. A., Caldwell, S. H., Kowdley, K. V., & Harrison, S. A. (2015) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x15611581 · Cited by 96
Is Fatty Liver Associated With Depression? A Meta-Analysis and Systematic Review on the Prevalence, Risk Factors, and Outcomes of Depression and Non-alcoholic Fatty Liver Disease
Xiao, J., Lim, L. K. E., Ng, C. H., Tan, D. J. H., Lim, W. H., Ho, C. S. H., Tan, E. X. X., Sanyal, A. J., & Muthiah, M. D. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.691696 · Cited by 94
Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options
Milić, S., Mikolašević, I., Zrnić, I. K., Stanić, M., Poropat, G., Štimac, D., Vlahović-Palčevski, V., & Orlić, L. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s64877 · Cited by 97
Polycystic ovary syndrome and endometrial hyperplasia: an overview of the role of bariatric surgery in female fertility
Charalampakis, V., Tahrani, A. A., Helmy, A., Gupta, J. K., & Singhal, R. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.10.001 · Cited by 88
Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans
Spinelli, V., Lalloyer, F., Baud, G., Osto, E., Kouach, M., Daoudi, M., Vallez, E., Raverdy, V., Goossens, J.-F., Descat, A., et al. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.46 · Cited by 97
Self-citation
Meta‐analysis of genome‐wide DNA methylation and integrative omics of age in human skeletal muscle
Voisin, S. A. C., Jacques, M., Landen, S., Harvey, N. R., Haupt, L. M., Griffiths, L. R., Gancheva, S., Ouni, M., Jähnert, M., Ashton, K. J., et al. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12741 · Cited by 93
Self-citation
Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy
Kalinowski, P., Paluszkiewicz, R., Ziarkiewicz‐Wróblewska, B., Wróblewski, T., Remiszewski, P., Grodzicki, M., & Krawczyk, M. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000002397 · Cited by 86
Perspectives on Treatment for Nonalcoholic Steatohepatitis
Lassailly, G., Caiazzo, R. J., Pattou, F. N., & Mathurin, P. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.004 · Cited by 87
Self-citation
The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: “NASHOST” prospective observational trial
Raj, P., Gomes, R. M., Kumar, S. S., Senthilnathan, P., Karthikeyan, P., Annapoorni, S., & Palanivelu, C. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.02.006 · Cited by 80
Bariatric surgery improves nonalcoholic fatty liver disease: systematic review and meta-analysis
Zhou, H., Luo, P., Li, P., wang, G., Yi, X., Fu, Z., Sun, X., Cui, B., Zhu, L., & Zhu, S. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06011-1 · Cited by 79
Changes in Bile Acid Profile After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Metabolic Profile and Fatty Liver Disease
Belgaumkar, A. P., Vincent, R. P., Carswell, K. A., Hughes, R. D., Alaghband-Zadeh, J., Mitry, R. R., le Roux, C. W., & Patel, A. G. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1878-1 · Cited by 80
The intersection of nonalcoholic fatty liver disease and obesity
Baidal, J. W., & Lavine, J. E. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad8390 · Cited by 75
Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?—a Controlled Matched Pair Study of 34 Patients
Billeter, A. T., Senft, J. D., Gotthardt, D. N., Knefeli, P., Nickel, F., Schulte, T., Fischer, L., Nawroth, P. P., Büchler, M. W., & Müller-Stich, B. P. (2015) · Obesity Surgery · doi:10.1007/s11695-015-2006-y · Cited by 75
Impact of Prior Bariatric Surgery on Perioperative Liver Transplant Outcomes
Idriss, R., Hasse, J. M., Wu, T., Khan, F., Saracino, G., McKenna, G. J., Testa, G., Trotter, J. F., Klintmalm, G. B. G., & Asrani, S. K. (2018) · Liver Transplantation · doi:10.1002/lt.25368 · Cited by 70
Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
Campos-Murguía, A., Ruiz‐Margáin, A., González-Regueiro, J. A., & Macías‐Rodríguez, R. U. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i39.5919 · Cited by 75
Gastric Bypass Compared with Sleeve Gastrectomy for Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
de Brito e Silva, M. B., Tustumi, F., de Miranda Neto, A. A., Dantas, A. C. B., Santo, M. A., & Cecconello, I. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05412-y · Cited by 66
Duodenal mucosal resurfacing: proof-of-concept, procedural development, and initial implementation in the clinical setting
Haidry, R. J., van Baar, A. C., Galvao Neto, M. P., Rajagopalan, H., Caplan, J., Levin, P. S., Bergman, J. J., Rodriguez, L., Deviere, J., & Thompson, C. C. (2019) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2019.03.024 · Cited by 66
NASH-related increases in plasma bile acid levels depend on insulin resistance
Grzych, G., Chávez‐Talavera, O., Descat, A., Thuillier, D., Verrijken, A., Kouach, M., Legry, V., Verkindt, H., Raverdy, V., Legendre, B. L., et al. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100222 · Cited by 67
Self-citation
Incidence and Predictive Factors of Postprandial Hyperinsulinemic Hypoglycemia After Roux-en-Y Gastric Bypass
Raverdy, V., Baud, G., Pigeyre, M., Verkindt, H., Torres, F., Preda, C., Thuillier, D., Gelé, P., Vantyghem, M., Caiazzo, R. J., et al. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001915 · Cited by 69
Self-citation
Decreased STARD10 Expression Is Associated with Defective Insulin Secretion in Humans and Mice
Carrat, G., Hu, M., Nguyen‐Tu, M., CHABOSSEAU, P. L., Gaulton, K. J., van de Bunt, M., Siddiq, A., Falchi, M., Thurner, M., Canouil, M., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.01.011 · Cited by 62
Self-citation
European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline
Bischoff, S. C., Barazzoni, R., Busetto, L., Campmans-Kuijpers, M. J. E., Cardinale, V., Chermesh, I., Eshraghian, A., Kani, H. T., Khannoussi, W., Lacaze, L., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.07.003 · Cited by 70
Systematic review and meta-analysis of Roux-en-Y gastric bypass against laparoscopic sleeve gastrectomy for amelioration of NAFLD using four criteria
Baldwin, D., Chennakesavalu, M., & Gangemi, A. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.09.060 · Cited by 57
Intestinal gluconeogenesis prevents obesity-linked liver steatosis and non-alcoholic fatty liver disease
Vily‐Petit, J., Soty, M., Silva, M., Raffin, M., Gautier‐Stein, A., Rajas, F., & Mithieux, G. (2020) · Gut · doi:10.1136/gutjnl-2019-319745 · Cited by 62
European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline
Bischoff, S. C., Barazzoni, R., Busetto, L., Campmans-Kuijpers, M. J. E., Cardinale, V., Chermesh, I., Eshraghian, A., Kani, H. T., Khannoussi, W., Lacaze, L., et al. (2022) · United European Gastroenterology Journal · doi:10.1002/ueg2.12280 · Cited by 62
Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis
Hwang, J., Hwang, H., Shin, H., Kim, B. H., Kang, S. H., Yoo, J., Choi, M. Y., Lee, D. E., Jun, D. W., & Cho, Y. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2023.0384 · Cited by 54
Adipose tissue macrophage infiltration and hepatocyte stress increase GDF-15 throughout development of obesity to MASH
L’homme, L., Sermikli, B. P., Haas, J. T., Fleury, S., Quemener, S., Guinot, V., Barreby, E., Esser, N., Caiazzo, R. J., Verkindt, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51078-2 · Cited by 51
Self-citation
Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review
Cazzo, E., Pareja, J. C., & Chaim, É. A. (2017) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2016.0306311216 · Cited by 54
Functional genomics uncovers the transcription factor BNC2 as required for myofibroblastic activation in fibrosis
Bobowski, M., Boulet, C., Zummo, F. P., Dubois‐Chevalier, J., Gheeraert, C., Saleh, M. B., Strub, J., Farce, A., Ploton, M., Guille, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33063-9 · Cited by 52
Self-citation
MASLD treatment—a shift in the paradigm is imminent
Machado, M. V. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1316284 · Cited by 51
Hepatic transcriptomic signatures of statin treatment are associated with impaired glucose homeostasis in severely obese patients
Margerie, D., Lefèbvre, P., Raverdy, V., Schwahn, U., Ruetten, H., Larsen, P. J., Duhamel, A., Labreuche, J., Thuillier, D., Derudas, B., et al. (2019) · BMC Medical Genomics · doi:10.1186/s12920-019-0536-1 · Cited by 48
Self-citation
Impact of Centralized Management of Bariatric Surgery Complications on 90-day Mortality
Caiazzo, R. J., Baud, G., Clément, G., Lenne, X., Torres, F., Dezfoulian, G., Lebuffe, G., Kipnis, É., Dervaux, B., & Pattou, F. N. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002949 · Cited by 47
Self-citation
Liver transplantation for bariatric surgery-related liver failure: a systematic review of a rare condition
Addeo, P., Cesaretti, M., Anty, R., & Iannelli, A. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.06.002 · Cited by 46
Bariatric surgery and the liver—Mechanisms, benefits, and risks
Lefere, S., Onghena, L., Vanlander, A., Nieuwenhove, Y. V., Devisscher, L., & Geerts, A. M. (2021) · Obesity Reviews · doi:10.1111/obr.13294 · Cited by 49
“Dysfunctions” induced by Roux-en-Y gastric bypass surgery are concomitant with metabolic improvement independent of weight loss
Li, M., Liu, Z., Qian, B., Liu, W., Horimoto, K., Xia, J. L., Shi, M., Wang, B., Zhou, H., & Chen, L. (2020) · Cell Discovery · doi:10.1038/s41421-019-0138-2 · Cited by 45
Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and sphingolipids independent of differences in weight loss
Kayser, B. D., Lhomme, M., Dao, M. C., Ichou, F., Bouillot, J., Prifti, E., Kontush, A., Chevallier, J., Aron‐Wisnewsky, J., Dugail, I., et al. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.63 · Cited by 46
Bariatric Surgery in NAFLD
Chauhan, M., Singh, K., & Thuluvath, P. J. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07317-3 · Cited by 48
Hydrothermal Duodenal Mucosal Resurfacing
Cherrington, A. D., Rajagopalan, H., MAGGS, D. G., & Deviere, J. M. E. (2017) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2016.12.002 · Cited by 45
Nonalcoholic Steatohepatitis Drug Development Pipeline: An Update
Chew, N., Ng, C. H., Truong, E., Noureddin, M., & Kowdley, K. V. (2022) · Seminars in Liver Disease · doi:10.1055/a-1877-9656 · Cited by 44
MANAGEMENT OF ENDOCRINE DISEASE: Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease
Ruissen, M. M., Mak, A. L., Beuers, U. H., Tushuizen, M. E., & Holleboom, A. G. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0065 · Cited by 45
Impact of laparoscopic sleeve gastrectomy on fibrosis stage in patients with child-A NASH-related cirrhosis
Salman, M. A., Mikhail, H. M. S., Nafea, M. A., Sultan, A. A. E. A., Elshafey, H. E., Tourky, M. S., Awad, A., Abouelregal, T. E., Ahmed, R. A., Ashoush, O. A., et al. (2020) · Surgical Endoscopy · doi:10.1007/s00464-020-07498-4 · Cited by 42
Management of non-alcoholic fatty liver disease in 2015
Malhotra, N. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i30.2962 · Cited by 41
Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH
Traussnigg, S., Kienbacher, C., Halilbasic, E., Rechling, C., Kazemi-Shirazi, L., Hofer, H., Munda, P., & Trauner, M. A. (2015) · Digestive Diseases · doi:10.1159/000375353 · Cited by 37
Reversal of fibrosis in patients with nonalcoholic steatohepatosis after gastric bypass surgery
Parker, B., Wu, J., You, J., Barnes, D., Yerian, L., Kirwan, J., Schauer, P., & Sessler, D. (2017) · BMC Obesity · doi:10.1186/s40608-017-0168-y · Cited by 34
Metabolic Effects of Gastric Bypass Surgery: Is It All About Calories?
Herzog, K., Berggren, J., Majdoub, M. A., Balderas, C., Lindqvist, A., Hedenbro, J., Groop, L., Wierup, N., & Spégel, P. (2020) · Diabetes · doi:10.2337/db20-0131 · Cited by 35
Performance of non-invasive tests for liver fibrosis resolution after bariatric surgery
Raverdy, V., Tavaglione, F., Chatelain, E., Caiazzo, R. J., Saponaro, C., Lassailly, G., Verkindt, H., Baud, G., Marciniak, C., Chetboun, M., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155790 · Cited by 33
Self-citation
A Predictive Model of Weight Loss After Roux-en-Y Gastric Bypass up to 5 Years After Surgery: a Useful Tool to Select and Manage Candidates to Bariatric Surgery
Seyssel, K., Suter, M., Pattou, F. N., Caiazzo, R. J., Verkindt, H., Raverdy, V., Jolivet, M., Disse, E., Robert, M., & Giusti, V. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3355-0 · Cited by 33
Self-citation
Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients
Brodosi, L., Petta, S., Petroni, M. L., Marchesini, G., & Morelli, M. C. (2021) · Transplantation · doi:10.1097/tp.0000000000003867 · Cited by 34
Updated S2k clinical practice guideline on non-alcoholic fatty liver disease (NAFLD) issued by the German society of gastroenterology, digestive and metabolic diseases (DGVS)–April 2022–AWMF Registration No.: 021–025
Authors, & Collaborators: (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1880-2388 · Cited by 30
Prevalence of NASH/NAFLD in people with obesity who are currently classified as metabolically healthy
Frey, S., Patouraux, S., Debs, T., Gugenheim, J., Anty, R., & Iannelli, A. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.07.009 · Cited by 30
A prospective 5-year study on the use of transient elastography to monitor the improvement of non-alcoholic fatty liver disease following bariatric surgery
Liu, S. Y., Wong, V. W., Wong, S. K., Wong, G. L., Lai, C. M., Lam, C. C., Shu, S. S., Chan, H. L., & Ng, E. K. (2021) · Scientific Reports · doi:10.1038/s41598-021-83782-0 · Cited by 29
Insulin Clearance After Oral and Intravenous Glucose Following Gastric Bypass and Gastric Banding Weight Loss
Shah, A. M., Holter, M. M., Rimawi, F., Mark, V., Dutia, R., McGinty, J., Levin, B. L., & Laferrère, B. (2018) · Diabetes Care · doi:10.2337/dc18-1036 · Cited by 29
Effects of Laparoscopic Sleeve Gastrectomy on Non-Alcoholic Steatohepatitis and Liver Fibrosis in Japanese Patients with Severe Obesity
Nikai, H., Ishida, K., Umemura, A., Baba, S., Nitta, H., Sugai, T., & Sasaki, A. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04515-2 · Cited by 28
Long-term effect of bariatric surgery on resolution of nonalcoholic steatohepatitis (NASH): An external validation and application of a clinical NASH score
Tan, C. H., Al-Kalifah, N., Ser, K., Lee, Y.-C., Chen, J., & Lee, W. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.05.024 · Cited by 28
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes
Godoy‐Matos, A. F., Valério, C. M., Júnior, W. S. D. S., Neto, J. M. D. A., & Bertoluci, M. C. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01259-2 · Cited by 30
The Impact of Bariatric Surgery on Hepatic Function and Predictors of Liver Steatosis and Fibrosis
CRIO group, Borges‐Canha, M., Neves, J. S., Mendonça, F. M., Silva, M. M., Costa, C. F., Cabral, P. M., Guerreiro, V. A., Lourenço, R., Meira, P., et al. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04622-0 · Cited by 26
Safety and Efficacy of Bariatric Surgery in Cirrhosis Patients With Extreme Obesity
Vuppalanchi, R., McCabe, M. E., Tandra, S., Parcha, S. P., Ghafoor, A., Schuh, L., Inman, M. M., Selzer, D. J., Stefanidis, D., & Chalasani, N. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003891 · Cited by 26
Nonalcoholic Fatty Liver Disease and Its Complex Relation with Type 2 Diabetes Mellitus—From Prevalence to Diagnostic Approach and Treatment Strategies
Diaconu, C.-T., & Guja, C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175144 · Cited by 29
Gastropleural fistula after single anastomosis gastric bypass. A case report and review of the literature
Alshurafa, H. A., Al‐Ghamdi, S. A., Albenmousa, A. H., Alolayan, H., & Al-Shurafa, Z. (2017) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2017.03.035 · Cited by 25
ASMBS Position Statement on medium- and long-term durability of weight loss and diabetic outcomes after conventional stapled bariatric procedures
Azagury, D. E., Papasavas, P. K., Hamdallah, I. N., Gagner, M., & Kim, J. J. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.08.001 · Cited by 25
Current strategies for nonalcoholic fatty liver disease treatment (Review)
Sun, J., Jin, X., & Li, Y. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5412 · Cited by 26
Monitoring of Liver Function Tests after Roux-en-Y Gastric Bypass: An Examination of Evidence Base
Mahawar, K. K., Parmar, C. D., Graham, Y. N. H., de Alwis, N. M. W., Carr, W. R. J., Jennings, N., & Small, P. K. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2280-3 · Cited by 24
Roux-en-Y gastric bypass increases systemic but not portal bile acid concentrations by decreasing hepatic bile acid uptake in minipigs
Chávez‐Talavera, O., Baud, G., Spinelli, V., Daoudi, M., Kouach, M., Goossens, J.-F., Vallez, E., Caiazzo, R. J., Ghunaim, M., Hübert, T., et al. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.7 · Cited by 24
Self-citation
Resolution of Metabolic Dysfunction-associated Steatohepatitis With No Worsening of Fibrosis After Bariatric Surgery Improves 15-year Survival: A Prospective Cohort Study
Lassailly, G., Caiazzo, R. J., Goemans, A., Chetboun, M., Gnemmi, V., Labreuche, J., Baud, G., Verkindt, H., Marciniak, C., Daoud, N. O., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.10.025 · Cited by 23
Self-citation
Diagnostic and Therapy of Nonalcoholic Fatty Liver Disease: A Narrative Review
Roeb, E. (2021) · Visceral Medicine · doi:10.1159/000519611 · Cited by 23
Nonalcoholic Fatty Liver Disease
Gawrieh, S. (2016) · Springer eBooks · doi:10.1007/978-3-319-30103-7_14 · Cited by 25
IMPACT OF CURRENT DIET AT THE RISK OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Duarte, S. M. B., Stefano, J. T., Vanni, D. S., Carrilho, F. J., & de Oliveira, C. P. M. S. (2019) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.201900000-67 · Cited by 24
Caring for children with NAFLD and navigating their care into adulthood
Mencin, A., Loomba, R. S., & Lavine, J. E. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.146 · Cited by 22
Baseline Presence of NAFLD Predicts Weight Loss after Gastric Bypass Surgery for Morbid Obesity
Rheinwalt, K. P., Drebber, U., Schierwagen, R., Klein, S., Neumann, U. P., Ulmer, T. F., Plamper, A., Kroh, A., Schipper, S., Odenthal, M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113430 · Cited by 22
Longitudinal Comparison of the Effect of Gastric Bypass to Sleeve Gastrectomy on Liver Function in a Bariatric Cohort: Tehran Obesity Treatment Study (TOTS)
Motamedi, M. A. K., Khalaj, A., Mahdavi, M., Valizadeh, M., Hosseinpanah, F., & Barzin, M. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3537-9 · Cited by 21

Authors: Caiazzo, R., Lassailly, G., Leteurtre, E., Baud, G., Verkindt, H., Raverdy, V., Buob, D., Pigeyre, M., Mathurin, P., & Pattou, F.
Affiliations: Inserm (FR)
Centre Hospitalier Universitaire de Lille (FR)
Corresponding author: Caiazzo, Robert
Verkindt, Hélène
Raverdy, Violeta
Pattou, François
ORCID: Caiazzo, Robert
Lassailly, Guillaume
Leteurtre, Emmanuelle
Verkindt, Hélène
Raverdy, Violeta
Buob, David
Pigeyre, Marie
Mathurin, Philippe
Pattou, François
Venue: Annals of Surgery
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2014-11
Volume: 260
Issue: 5
Pages: 893-899
ISSN: 0003-4932 (ISSN-L)
DOI: 10.1097/sla.0000000000000945
OpenAlex: W2332106446
Cited by: 226
References: 21
Citations by year: 2026: 7 · 2025: 4 · 2024: 11 · 2023: 15 · 2022: 25 · 2021: 31 · 2020: 27 · 2019: 24 · 2018: 22 · 2017: 20 · 2016: 18 · 2015: 20 · 2014: 1
FWCI: 19.40
Type: journal article
Language: en
Open access: closed
Locations: Annals of Surgery (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
Keywords: Roux-en-Y gastric bypass, gastric banding, non-alcoholic fatty liver disease, bariatric surgery, morbid obesity, liver histopathology, NAFLD activity score, hepatic steatosis, liver fibrosis, weight loss, long-term outcomes, liver biopsy histology, NAFLD progression
MeSH terms: Biopsy, Female, Humans, Longitudinal Studies, Male, Middle Aged, Obesity, Morbid, Prospective Studies, Gastric Bypass, Gastroplasty, Body Mass Index, Treatment Outcome, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Roux-en-Y Gastric Bypass Versus Adjustable Gastric Banding to Reduce Nonalcoholic Fatty Liver Disease: A 5-Year Controlled Longitudinal Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks